Debt Securities, Available-for-Sale, Unrealized Loss Position
Moderna Debt Securities, Available-for-Sale, Unrealized Loss Position increased by 175.0% to $11.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.4%, from $13.00M to $11.00M. Over 4 years (FY 2021 to FY 2025), Debt Securities, Available-for-Sale, Unrealized Loss Position shows a downward trend with a -47.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase indicates a broader decline in the market value of the debt portfolio relative to its cost basis.
Detailed definition
The aggregate fair value of all debt securities classified as available-for-sale that are currently in an unrealized los...
Peer comparison
Used to gauge the overall sensitivity of the investment portfolio to market price changes.
other_debt_securities_available_for_sale_unrealized_loss_ab3ae9Historical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $52.00M | $271.00M | $378.00M | $549.00M | $464.00M | $348.00M | $335.00M | $268.00M | $151.00M | $125.00M | $94.00M | $34.00M | $28.00M | $13.00M | $9.00M | $5.00M | $4.00M | $11.00M |
| QoQ Change | — | +421.2% | +39.5% | +45.2% | -15.5% | -25.0% | -3.7% | -20.0% | -43.7% | -17.2% | -24.8% | -63.8% | -17.6% | -53.6% | -30.8% | -44.4% | -20.0% | +175.0% |
| YoY Change | — | — | — | — | +792.3% | +28.4% | -11.4% | -51.2% | -67.5% | -64.1% | -71.9% | -87.3% | -81.5% | -89.6% | -90.4% | -85.3% | -85.7% | -15.4% |
Debt Securities, Available-for-Sale, Unrealized Loss Position at Other Companies
Frequently Asked Questions
- What is Moderna's debt securities, available-for-sale, unrealized loss position?
- Moderna (MRNA) reported debt securities, available-for-sale, unrealized loss position of $11.00M in Q1 2026.
- How has Moderna's debt securities, available-for-sale, unrealized loss position changed year-over-year?
- Moderna's debt securities, available-for-sale, unrealized loss position decreased by 15.4% year-over-year, from $13.00M to $11.00M.
- What is the long-term trend for Moderna's debt securities, available-for-sale, unrealized loss position?
- Over 4 years (2021 to 2025), Moderna's debt securities, available-for-sale, unrealized loss position has grown at a -47.3% compound annual growth rate (CAGR), from $52.00M to $4.00M.
- What does debt securities, available-for-sale, unrealized loss position mean?
- The total market value of all debt investments currently worth less than what was paid for them.